(b)(4).Only event year known: 2020; captured as citation date.As the device was not returned, an analysis investigation could not be performed.A conclusion could not be reached as to what may have caused or contributed to the event.The lot number was not provided; therefore, a manufacturing record evaluation could not be performed.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|
It was reported via journal article: title: safety and efficacy of an implantable device for management of gastroesophageal reflux in lung transplant recipients author: samantha e.Halpern, aryaman gupta, vignesh raman, oliver k.Jawitz, ashley y.Choi, hai salfity, john c.Haney, jacob a.Klapper, matthew g.Hartwig citation: not reported doi: not reported this study is consisted of 14 lung transplant recipients (ltx) with gerd who underwent treatment with linx reflux management system (msa device) (ethicon) between 2017-2019.Persistent dysphagia requiring device dilation (n=3), subsequent device explant (n=2) at day 77 and 448 after implantation, vomiting (n=unknown) and throat pain (n=unknown) were the reported complications.Ltx recipients who underwent linx device implantation demonstrated a significant decrease in esophageal acid exposure time without major complications up to 12 months post-operatively.Use of the linx msa is a safe and effective method for management of post-ltx gerd in this highrisk population.
|